Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor

  • Llorens, Franc
  • Hummel, Manuela
  • Pantano Rubiño, Lorena, 1982-
  • Pastor, Xavier
  • Vivancos Prellezo, Ana
  • Castillo Andreo, Esther
  • Mattlin, Heidi
  • Ferrer Admetlla, Anna
  • Ingham, Matthew
  • Noguera, Marc
  • Kofler, Robert
  • Dohm, Juliane C.
  • Pluvinet, Raquel
  • Bayés, Mònica
  • Himmelbauer, Heinz
  • del Río, José Antonio
  • Martí, Eulàlia
  • Sumoy Van Dyck, Lauro
Background: Epidermal Growth Factor (EGF) plays an important function in the regulation of cell growth, proliferation, and differentiation by binding to its receptor (EGFR) and providing cancer cells with increased survival responsiveness. Signal transduction carried out by EGF has been extensively studied at both transcriptional and post-transcriptional levels. Little is known about the involvement of microRNAs (miRNAs) in the EGF signaling pathway. miRNAs have emerged as major players in the complex networks of gene regulation, and cancer miRNA expression studies have evidenced a direct involvement of miRNAs in cancer progression. Results: In this study, we have used an integrative high content analysis approach to identify the specific miRNAs implicated in EGF signaling in HeLa cells as potential mediators of cancer mediated functions. We have used microarray and deep-sequencing technologies in order to obtain a global view of the EGF miRNA transcriptome with a robust experimental cross-validation. By applying a procedure based on Rankprod tests, we have delimited a solid set of EGF-regulated miRNAs. After validating regulated miRNAs by reverse transcription quantitative PCR, we have derived protein networks and biological functions from the predicted targets of the regulated miRNAs to gain insight into the potential role of miRNAs in EGF-treated cells. In addition, we have analyzed sequence heterogeneity due to editing relative to the reference sequence (isomiRs) among regulated miRNAs. Conclusions: We propose that the use of global genomic miRNA cross-validation derived from high throughput technologies can be used to generate more reliable datasets inferring more robust networks of co-regulated predicted miRNA target genes., This work was supported by grants from Ministerio de Ciencia e Innovación [MICINN; BFU2012-32617] to JADR and FL, Generalitat de Catalunya [SGR2009-366] to JADR and FL, and the EU-FP7 PRIORITY to JADR. Start up funds from the Institute for Predictive and Personalized Medicine of Cancer and the Center for Genomic Regulation to LS; by the Spanish Ministry of Science and Technology [SAF2004-06976] to LS, Juan de la Cierva researcher contract to FL, and by excellence in research team recognitions by the Catalan government, Departament de Innovació, Universitats i Ensenyament, Generalitat de Catalunya [SGR2005-404] to LS, and by the Instituto de Salud Carlos III Fondo de Investigaciones Sanitarias to JADR and to LS [PI10/01154]
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis

  • Llorens, Franc
  • Hummel, Manuela
  • Pastor Ruiz, Javier
  • Ferrer Salvador, Anna
  • Pluvinet, Raquel
  • Vivancos Prellezo, Ana
  • Castillo Andreo, Esther
  • Iraola Guzmán, Susana
  • Mosquera Miguel, Ana
  • González-Roca, Eva
  • Lozano, Juan José
  • Ingham, Matthew
  • Dohm, Juliane C.
  • Noguera, Marc
  • Kofler, Robert
  • Río, Jose Antonio del
  • Bayés, Mònica
  • Himmelbauer, Heinz
  • Sumoy Van Dyck, Lauro
Background: Epidermal Growth Factor (EGF) is a key regulatory growth factor activating many processes relevant to normal development and disease, affecting cell proliferation and survival. Here we use a combined approach to study the EGF dependent transcriptome of HeLa cells by using multiple long oligonucleotide based microarray platforms (from Agilent, Operon, and Illumina) in combination with digital gene expression profiling (DGE) with the Illumina Genome Analyzer. Results: By applying a procedure for cross-platform data meta-analysis based on RankProd and GlobalAncova tests, we establish a well validated gene set with transcript levels altered after EGF treatment. We use this robust gene list to build higher order networks of gene interaction by interconnecting associated networks, supporting and extending the important role of the EGF signaling pathway in cancer. In addition, we find an entirely new set of genes previously unrelated to the currently accepted EGF associated cellular functions. Conclusions: We propose that the use of global genomic cross-validation derived from high content technologies (microarrays or deep sequencing) can be used to generate more reliable datasets. This approach should help to improve the confidence of downstream in silico functional inference analyses based on high content data., This work was supported by start up funds from the institute for Predictive and Personalized Medicine of Cancer and the Center for Genomic Regulation [core funding to L.S.]; by the Spanish Ministry of Science and Technology [grant number SAF2004-06976 to L.S., Juan de la Cierva researcher contract to F.L., and technician contracts for support of technological infrastructures to E.G. and A.F.]; and by excellence in research team recognitions by the Catalan government, Departament de Innovació, Universitats i Ensenyament, Generalitat de Catalunya [Singular Research Group award number SGR2005-404 to L.S and SGR2009-0366 to J.A.D.R., by the Instituto de Salud Carlos III Fondo de Investigaciones Sanitarias [grant number PI10/01154 to L.S.] and to J.A.D.R, by the Spanish Ministry of Science and Technology to F.L. and J.A.D.R
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis

  • Llorens, Franc
  • Hummel, Manuela
  • Pastor Ruiz, Javier
  • Ferrer Salvador, Anna
  • Pluvinet, Raquel
  • Vivancos Prellezo, Ana
  • Castillo Andreo, Esther
  • Iraola Guzmán, Susana
  • Mosquera Miguel, Ana
  • González-Roca, Eva
  • Lozano, Juan José
  • Ingham, Matthew
  • Dohm, Juliane C.
  • Noguera, Marc
  • Kofler, Robert
  • Río, Jose Antonio del
  • Bayés, Mònica
  • Himmelbauer, Heinz
  • Sumoy Van Dyck, Lauro
Background: Epidermal Growth Factor (EGF) is a key regulatory growth factor activating many processes relevant to normal development and disease, affecting cell proliferation and survival. Here we use a combined approach to study the EGF dependent transcriptome of HeLa cells by using multiple long oligonucleotide based microarray platforms (from Agilent, Operon, and Illumina) in combination with digital gene expression profiling (DGE) with the Illumina Genome Analyzer. Results: By applying a procedure for cross-platform data meta-analysis based on RankProd and GlobalAncova tests, we establish a well validated gene set with transcript levels altered after EGF treatment. We use this robust gene list to build higher order networks of gene interaction by interconnecting associated networks, supporting and extending the important role of the EGF signaling pathway in cancer. In addition, we find an entirely new set of genes previously unrelated to the currently accepted EGF associated cellular functions. Conclusions: We propose that the use of global genomic cross-validation derived from high content technologies (microarrays or deep sequencing) can be used to generate more reliable datasets. This approach should help to improve the confidence of downstream in silico functional inference analyses based on high content data., This work was supported by start up funds from the institute for Predictive and Personalized Medicine of Cancer and the Center for Genomic Regulation [core funding to L.S.]; by the Spanish Ministry of Science and Technology [grant number SAF2004-06976 to L.S., Juan de la Cierva researcher contract to F.L., and technician contracts for support of technological infrastructures to E.G. and A.F.]; and by excellence in research team recognitions by the Catalan government, Departament de Innovació, Universitats i Ensenyament, Generalitat de Catalunya [Singular Research Group award number SGR2005-404 to L.S and SGR2009-0366 to J.A.D.R., by the Instituto de Salud Carlos III Fondo de Investigaciones Sanitarias [grant number PI10/01154 to L.S.] and to J.A.D.R, by the Spanish Ministry of Science and Technology to F.L. and J.A.D.R
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor

  • Llorens, Franc
  • Hummel, Manuela
  • Pantano Rubiño, Lorena, 1982-
  • Pastor, Xavier
  • Vivancos Prellezo, Ana
  • Castillo Andreo, Esther
  • Mattlin, Heidi
  • Ferrer Admetlla, Anna
  • Ingham, Matthew
  • Noguera, Marc
  • Kofler, Robert
  • Dohm, Juliane C.
  • Pluvinet, Raquel
  • Bayés, Mònica
  • Himmelbauer, Heinz
  • del Río, José Antonio
  • Martí, Eulàlia
  • Sumoy Van Dyck, Lauro
Background: Epidermal Growth Factor (EGF) plays an important function in the regulation of cell growth, proliferation, and differentiation by binding to its receptor (EGFR) and providing cancer cells with increased survival responsiveness. Signal transduction carried out by EGF has been extensively studied at both transcriptional and post-transcriptional levels. Little is known about the involvement of microRNAs (miRNAs) in the EGF signaling pathway. miRNAs have emerged as major players in the complex networks of gene regulation, and cancer miRNA expression studies have evidenced a direct involvement of miRNAs in cancer progression. Results: In this study, we have used an integrative high content analysis approach to identify the specific miRNAs implicated in EGF signaling in HeLa cells as potential mediators of cancer mediated functions. We have used microarray and deep-sequencing technologies in order to obtain a global view of the EGF miRNA transcriptome with a robust experimental cross-validation. By applying a procedure based on Rankprod tests, we have delimited a solid set of EGF-regulated miRNAs. After validating regulated miRNAs by reverse transcription quantitative PCR, we have derived protein networks and biological functions from the predicted targets of the regulated miRNAs to gain insight into the potential role of miRNAs in EGF-treated cells. In addition, we have analyzed sequence heterogeneity due to editing relative to the reference sequence (isomiRs) among regulated miRNAs. Conclusions: We propose that the use of global genomic miRNA cross-validation derived from high throughput technologies can be used to generate more reliable datasets inferring more robust networks of co-regulated predicted miRNA target genes., This work was supported by grants from Ministerio de Ciencia e Innovación [MICINN; BFU2012-32617] to JADR and FL, Generalitat de Catalunya [SGR2009-366] to JADR and FL, and the EU-FP7 PRIORITY to JADR. Start up funds from the Institute for Predictive and Personalized Medicine of Cancer and the Center for Genomic Regulation to LS; by the Spanish Ministry of Science and Technology [SAF2004-06976] to LS, Juan de la Cierva researcher contract to FL, and by excellence in research team recognitions by the Catalan government, Departament de Innovació, Universitats i Ensenyament, Generalitat de Catalunya [SGR2005-404] to LS, and by the Instituto de Salud Carlos III Fondo de Investigaciones Sanitarias to JADR and to LS [PI10/01154]